Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease

Journal Article · · Biochemical and Biophysical Research Communications
 [1]; ;  [1];  [2];  [1];  [1]
  1. Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032 (China)
  2. Department of Radiology, Zhongshan Hospital of Fudan University and Shanghai Institute of Medical Imaging, Shanghai 200032 (China)

Highlights: •FXR activity was impaired by chronic ethanol ingestion in a murine model of ALD. •Activation of FXR attenuated alcohol-induced liver injury and steatosis. •Activation of FXR attenuated cholestasis and oxidative stress in mouse liver. -- Abstract: Alcoholic liver disease (ALD) is a common cause of advanced liver disease, and considered as a major risk factor of morbidity and mortality worldwide. Hepatic cholestasis is a pathophysiological feature observed in all stages of ALD. The farnesoid X receptor (FXR) is a member of the nuclear hormone receptor superfamily, and plays an essential role in the regulation of bile acid, lipid and glucose homeostasis. However, the role of FXR in the pathogenesis and progression of ALD remains largely unknown. Mice were fed Lieber-DeCarli ethanol diet or an isocaloric control diet. We used a specific agonist of FXR WAY-362450 to study the effect of pharmacological activation of FXR in alcoholic liver disease. In this study, we demonstrated that FXR activity was impaired by chronic ethanol ingestion in a murine model of ALD. Activation of FXR by specific agonist WAY-362450 protected mice from the development of ALD. We also found that WAY-362450 treatment rescued FXR activity, suppressed ethanol-induced Cyp2e1 up-regulation and attenuated oxidative stress in liver. Our results highlight a key role of FXR in the modulation of ALD development, and propose specific FXR agonists for the treatment of ALD patients.

OSTI ID:
22242235
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 1 Vol. 443; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner
Journal Article · Sat Jan 14 23:00:00 EST 2017 · Toxicology and Applied Pharmacology · OSTI ID:22690900

Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis
Journal Article · Fri May 23 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22416437

Activation of farnesoid X receptor induces RECK expression in mouse liver
Journal Article · Thu Jan 02 23:00:00 EST 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22242246